ArticleFrontiers in medicine2026

Dupilumab enables glucocorticoid withdrawal in refractory multisite mucous membrane pemphigoid: a case report.

Yuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.